company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13535000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13535000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1316000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-167000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1736000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,706000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9944000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9944000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-563000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,2000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-561000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-561000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-169000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,12508000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,48000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,12387000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,12387000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1882000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q1,2011-01-01,2011-03-31,2012-05-15 12:07:42+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,6000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29196000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29196000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1354000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-218000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2624000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5035000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20401000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20401000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1270000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1271000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1271000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-138000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,64441000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,409000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,64712000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,64712000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,43040000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q2,2011-04-01,2011-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,4000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18724000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18724000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1359000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-182000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1955000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-425000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16017000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16017000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-635000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,7000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-628000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-628000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-87000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,329000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,242000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,242000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16403000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q3,2011-07-01,2011-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,2000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18221000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18221000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,567000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,567000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1501000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,9131000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6455000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6455000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1286000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-1000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-1287000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-1287000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-49000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1946000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-786000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1745000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1036000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1036000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8778000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24893000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24893000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,721000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1441000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3297000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19434000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19434000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1765000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-41840000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,28380000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-147000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-15372000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-15372000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-48000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-59000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,41128000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-1885000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,5427000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,44611000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,44611000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,9805000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,169000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28323000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28323000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,700000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2911000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3592000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21196000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-21196000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2354000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-7090000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,20950000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,11506000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,11506000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,212000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,199000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,411000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,411000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9279000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q1,2013-01-01,2013-03-31,2014-05-06 16:28:53+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,998000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30251000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30251000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,619000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2684000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2638000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-24234000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-24234000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-951000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1200000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,28060000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-39000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,25870000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,25870000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-195000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-212000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,274000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1005000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,872000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,872000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2508000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q2,2013-04-01,2013-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1078000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39763000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-39763000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,607000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3974000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,12862000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-22320000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-22320000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5756000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-70409000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,25130000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-17000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-51052000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-51052000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,195000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,3000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,120621000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,27067000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,147880000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,147880000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,74508000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q3,2013-07-01,2013-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,773000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32348000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32348000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,663000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4482000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-222000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-27425000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-27425000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-796000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-34224000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,20960000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-14063000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-14063000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-120621000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,121263000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,26716000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-26235000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1123000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1123000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-40365000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1066000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27754000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27754000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,886000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5079000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9598000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-31387000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-31387000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1438000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5100000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,37602000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,31064000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,31064000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2134000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2134000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2134000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1811000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q1,2014-01-01,2014-03-31,2015-05-07 17:01:20+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,3836000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18290000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18290000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1355000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6275000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-22173000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-32833000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-32833000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1545000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-15000000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,57131000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,40586000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,40586000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,300000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2802000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3101000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3101000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,10854000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q2,2014-04-01,2014-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1079000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28038000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28038000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,570000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5412000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,83153000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,61097000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,61097000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1731000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-50834000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12000000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-40565000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-40565000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2040000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2040000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,22572000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q3,2014-07-01,2014-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3891000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9477000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9477000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,412000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5800000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-28420000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-31685000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-31685000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1321000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-40898000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5125000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-2000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-37096000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-37096000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-7000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-7000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1043000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,-700000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3803000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4146000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4146000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-64635000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,704000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34432000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34432000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1054000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5307000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7008000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-35079000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-35079000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1204000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,25163000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,23959000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,23959000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,1129000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3136000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4265000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4265000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6855000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q1,2015-01-01,2015-03-31,2016-05-02 17:17:33+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,3868000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22902000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22902000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1038000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7068000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9782000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-24578000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-24578000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2901000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,28800000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,25899000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,25899000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,104000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,3406000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3510000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3510000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4831000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q2,2015-04-01,2015-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1078000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-42386000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-42386000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2228000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5783000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8016000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-42391000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-42391000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-4022000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,27936000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,23914000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,23914000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,850000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,38560000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1753000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,41163000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,41163000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,22686000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q3,2015-07-01,2015-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,3891000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-48067000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,3832000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-51899000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,-1070000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3224000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,41965000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7780000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,4472000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3308000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3775000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6000000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2225000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromdiscontinuedinvestingactivities,Net Cash From Discontinued Investing Activities,+,debit,usd,-887000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1338000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-40000000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,169434000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1792000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,131226000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,131226000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,129256000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1250000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-38658000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,-943000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37715000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1198000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4700000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-896000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-32713000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,-20810000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-53523000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1229000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-84262000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-85491000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-85491000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1645000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1645000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1645000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-137369000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:53:37+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,2813000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-50958000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,675000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-51633000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1135000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,19676000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6363000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-37185000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,-13718000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-50903000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-821000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,23000000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,22179000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,22179000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,1025000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,953000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1978000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1978000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-26746000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q2,2016-04-01,2016-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,-2813000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30275000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,-3430000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26845000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1848000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3300000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4789000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16908000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,-18010000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-34918000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-818000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,49160000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,48342000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,48342000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-21000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-1025000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2594000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1548000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1548000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,14972000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q3,2016-07-01,2016-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,13851000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33627000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,6464000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-40091000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,714000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8287000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5039000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-36129000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,5232000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-30897000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,228000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12000000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,12228000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromdiscontinuedinvestingactivities,Net Cash From Discontinued Investing Activities,+,debit,usd,-515000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,11713000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-148000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,3361000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1032000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4245000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4245000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14939000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2016.0,Q4,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,10063000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30153000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,-947000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29206000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1182000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2304000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,7596000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18124000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,7968000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10156000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-290000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-290000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-290000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,6077000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,6077000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,6077000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4369000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 10:40:17+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,1368000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,510839000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,540485000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29646000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,876000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,18884000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-960000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10846000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,-54384000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-65230000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,290000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1391000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,575000000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,576681000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,576107000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-195124000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-140000000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,2601000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-332523000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-332523000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,178354000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q2,2017-04-01,2017-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,27504000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3133000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,8456000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5323000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,755000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-15133000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-14386000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-34087000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,8452000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-25635000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4454000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1833000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1833000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1833000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-28256000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1378000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q3,2017-07-01,2017-09-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,6122000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12951000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,-1122000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11829000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2408000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,182000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-11850000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-21089000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromdiscontinuedoperatingactivities,Net Cash From Discontinued Operating Activities,+,debit,usd,-3701000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-24790000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-186000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,5714000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5528000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5528000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-54950000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,400000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-54550000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-54550000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-73812000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,716000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2017.0,Q4,2017-10-01,2017-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,1804000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 08:31:15+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17782000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 08:31:15+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17782000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 08:31:15+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1239000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 08:31:15+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-141000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 08:31:15+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1459000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 08:31:15+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2114000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 08:31:15+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17339000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 08:31:15+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17339000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 08:31:15+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-16000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 08:31:15+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-41818000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 08:31:15+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-41834000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 08:31:15+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-41834000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 08:31:15+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-59173000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17769000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17769000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1019000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-82000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1646000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1057000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16243000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16243000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-102000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6513000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,11050000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4435000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4435000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11808000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3989000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,16330000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12341000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,953000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-175000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-4148000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2597000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13114000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13114000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-28526000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,23000000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,31150000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,25624000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,25624000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,14632000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,14632000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,14632000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,27142000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q3,2018-07-01,2018-09-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,235000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8944000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,3931000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12875000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,863000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-253000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-245000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6382000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18892000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18892000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-26198000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,75000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,5000000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10300000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-10823000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-10823000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-29715000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,351000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2018.0,Q4,2018-10-01,2018-12-31,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,390000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10458000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10458000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1219000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-216000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,442000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4639000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13652000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13652000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,615000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,29500000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,30115000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,30115000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,16463000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,,cashinterestpaid,Cash Interest Paid,=,,usd,361000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 16:06:16+00:00,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,10000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9430000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9430000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1009000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-63000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-605000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2784000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11873000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11873000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1410000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,7800000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19000000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,28210000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,28210000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-15985000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,23000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-15962000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-15962000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,375000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,,,cashinterestpaid,Cash Interest Paid,=,,usd,1038000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q2,2019-04-01,2019-06-30,,,cashincometaxespaid,Cash Income Taxes Paid,=,,usd,-10000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q3,2018-10-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-705000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q3,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-705000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q3,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-13000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q3,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-2797000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q3,2018-10-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,312000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q3,2018-10-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3203000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q3,2018-10-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3203000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q3,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,3500000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q3,2018-10-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3000000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q3,2018-10-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,6500000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q3,2018-10-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,6500000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q3,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-20000000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q3,2018-10-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,60000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q3,2018-10-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-19940000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q3,2018-10-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-19940000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q3,2018-10-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16643000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q4,2018-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,3261000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q4,2018-10-01,2019-12-31,,netincomecontinuing,netincomediscontinued,Net Income / (Loss) Discontinued Operations,-,credit,usd,3935000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q4,2018-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-674000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q4,2018-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-913000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q4,2018-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1053000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q4,2018-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2640000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q4,2018-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2640000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q4,2018-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,5000000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q4,2018-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5000000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q4,2018-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5000000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q4,2018-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,paymentofdividends,Payment of Dividends,+,debit,usd,-6700000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q4,2018-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,62000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q4,2018-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-6638000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q4,2018-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-6638000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q4,2018-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4278000.0
Merrimack Pharmaceuticals Inc,MACK,,0001274792,2019.0,Q4,2018-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1000.0
